During an ischemic stroke, blood vessels in the brain are blocked or narrowed. During a hemorrhagic stroke, there's bleeding ...

Market Trend: A notable trend in the acute ischemic stroke therapeutics market is the advancement of reperfusion therapies. The use of tissue plasminogen activator (tPA) has been a standard ...

The ReMEDy2 trial removes all MT+tPA patients from its calculus ... industry sponsored phase 2 or 3 trials targeting acute ischemic stroke in the last 5 years in the US. Of these, two seemed ...

My neighbor had a stroke and received a "clot buster" medication. Then, I found out my uncle had a surgery after a stroke.

Ischemic stroke is a severe reduction of blood ... The most commonly employed treatment, intravenous tissue plasminogen activator, is making a minor impact on this major public health problem ...

Use of recombinant tissue plasminogen activator (alteplase) for treatment of acute ischemic stroke outside the criteria of guidelines and licenses is not uncommon. Most important situations of off ...

This study explores the interaction between structural racism, urbanity, and the administration of acute ischemic stroke (AIS) interventions—specifically, intravenous thrombolysis (TPA) and ...

Background and Purpose: In the current era, where mechanical thrombectomy (MT) has become the gold standard for treating large vessel occlusions in acute ischemic stroke, the role of intravenous ...

Research has long shown that high levels bacteria linked to gum disease can raise the likelihood of the condition as well as ...

Remedy Pharmaceuticals, the developer of CIRARA (intravenous glyburide) for the treatment of Large Hemispheric Infarction (LHI) today announced three speaker presentations of efficacy data from both ...